BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma

Research output: Contribution to journalArticlepeer-review

21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences